Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age35-60
SponsorDar Al Uloom University
About this trial
The goal of this clinical trial is to assess Honey in orabase (1:1) for treating patients with OLP and improving their quality of life:
The research question aims to answer:
Does honey in orabase (1:1) improve or reduce OLP symptoms compared to the standardized treatment by triamcinolone acetonide 0.1% drug and improve the patient's quality of life?
Participants will:
Take drug ABC or a placebo every day for 4 months Visit the clinic once every 2 weeks for checkups and tests Keep a diary of their symptoms and the number of times they use a rescue inhaler
Eligibility criteria
Qualifiers
Patients with a clinical diagnosis of oral lichen planus
Symptomatic OLP lesions (erosive/atrophic)
Participants are between 35 and 60 years old, who are able to adhere to the study protocol, and sign informed consent.
Disqualifiers
Patients with other oral mucosal disorders, or systemic conditions influencing OLP or wound healing, allergies or hypersensitivity to honey or triamcinolone
Patients who administer systemic corticosteroids or immunosuppressive agents.
Pregnancy or lactation
Inability to comprehend or adhere to study directives
Trial design
Treatments tested in this trial
- Honey in orabase 1: 1 paste
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov